Will targeting B cells be the answer for Sjögren's syndrome?
- PMID: 17469093
- DOI: 10.1002/art.22604
Will targeting B cells be the answer for Sjögren's syndrome?
Comment on
-
BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren's syndrome.Arthritis Rheum. 2007 May;56(5):1464-77. doi: 10.1002/art.22603. Arthritis Rheum. 2007. PMID: 17469105 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
